For example, in a small size cohort study, high FGFR4 expression correlated with tumor progression and survival in both diffuse and intestinal GC, whereas high expression of FGFR1 and 2 correlated with tumor progression and survival only in diffuse type GC [111]. Here, FGFR1 is linked to gastric cancer.